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strut allografts, either alone or in conjunction with
metallic plate or cancellous bone allografts, are a
valuable adjunct for reconstructive surgery of the
hip and to treat atrophic femoral nonunion.
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Introduction
The orthopaedic surgeon can avail himself of a wide
spectrum of surgical techniques for the treatment
of musculoskeletal diseases. These techniques in-
volve, among others, the use of bone allografts and
synthetic bone substitutes. Bone allografts have
long been used as a natural substitute to repair
skeletal defects. They offer an attractive alternative
to bone autograft because their supply is unlimi ted,
they allow structural restoration of the skeleton,
and their surfaces support bone formation. Ap-
proximately 1 million musculoskeletal allografts
were distributed for use in the United States in
20041-3.
Different kinds of bone allograft are available to
the surgeon, and the clinical applications for each
type are dictated by the structure and biochemical
properties of the allograft. Cancellous bone allo-
graft and demineralized bone matrix (DBM) are
used to fill cavitary defects, facilitate spinal ar thro -
desis, and repair nonunions. They can also be used
as a cancellous autograft extender in these situa-
tions. Cortical bone allografts are used for bridging
structural defects in long bones, spinal arthrodesis,
buttress or strut grafts in limb salvage procedures,
revision arthroplasty, and periprosthetic fractures.
Advantages include vast supply and selection of
bones to fit a specific need, and matching to better
serve a given function2,4,5.
The major concern regarding the use of allograft
materials is the possibility of viral disease trans-
mission, including hepatitis C and HIV. However,
the risk of disease transmission will be remote if the
Abstract
Many approaches are used in the repair of skeletal
defects in reconstructive orthopaedic surgery, and
bone grafting is involved in virtually every proce-
dure. Autografting remains the gold standard for
replacing bone loss. However, the limited amount
of bone that can be harvested and the morbidity as-
sociated with that procedure are major constraints
to the clinical use of autografts. In contrast, bone
allografts can be used in any kind of surgery,
whether involving minor defects or major bone
loss. Cortical strut allografts unite to host bone
through callus formation, restoring bone stock and
can be used as an onlay biological plate. These
struts can be made from hemicylinders of tibia be-
ing fixed to host bone by circumferential metallic
cables or by screws.
The purpose of this study was to analyze the ra-
diographic outcomes of twelve cryopreserved cor-
tical onlay strut allografts, used in a group of nine
patients, for revision hip arthroplasty of the femoral
side, to stabilize femoral periprosthetic fractures, to
reinforce poor cortical bone and to treat one at-
rophic femoral nonunion. The average follow-up
period was 4.3 years (range, 1.6 to 9 years).
No fractures, nonunions or progressive resorp-
tion of the bone allografts were observed. All struts
were incorporated to the native femur with mini-
mal resorption, within the first year after surgery.
There was no failure of any of the allograft recons -
tructions.
The results obtained show that cortical onlay
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protocols of the quality assurance are followed and
the quarantine period is respected6.On the other
hand, host response to bone allografts is still poor-
ly understood. Experimental works have shown re-
duced immunogenicity when grafts were deep
frozen and a marked decrease when freeze-dried.
Clearly, the immune system plays an important
role in bone graft incorporation, but the exact na-
ture of this relationship is unknown7.
Synthetic or engineered bone graft substitutes
present the opportunity to provide materials that
enhance bone regeneration without concerns of
disease transmission or availability. However, these
biomaterials are not appropriate for structural re-
construction because they are weak in terms of
mechanical resistance. Synthetic graft substitutes
consist of an osteoconductive matrix to which os-
teoinductive proteins and/or osteoprogenitor cells
may be added8.
Cortical strut allografts are diaphyseal segments
of bone allograft. They are made from hemicylin-
ders of tibia, femur or humerus or full circumfe -
rential segments of fibula9,10. In our institution, ti -
bial struts are mainly used for revision arthroplas-
ty of the hip on the femoral side, with the follo wing
indications: to restore bone stock for noncircum-
ferential loss of cortical bone, to reinforce the re-
pair of cortical windows, to bypass stress risers,
and as a biological plate to stabilize periprosthe tic
fractures.
The clinical success of bone transplantation de-
pends on many factors, some related to the host
and others to the allograft and/or the donor, name-
ly the site of transplantation, the quality of the bone
bed from witch most of the revascularization ari -
ses, the host bed preparation, the preservation
techniques used to store the allograft bone, sys-
temic and local diseases, and mechanical stability
of the host-graft interface. These factors are large-
ly reliant on the surgeon and emphasize the im-
portance of the surgical technique. The host bed
must be prepared to leave bleeding bone. For op-
timal incorporation of the allograft, the host bed
should either already contain enough pre-os-
teogenic or osteogenic cells, or must be enriched
with a source of these cells, such as autograft or au-
togenous bone marrow11,12.
A radiographic study was performed on twelve
cryopreserved cortical strut allografts, which were
used in reconstructive surgery of the hip and in
proximal femoral fractures, with an average fol-
low-up period of 4.3 years.
Materials and Methods
Nine patients were treated with cortical strut allo-
grafts: one man and eight women with an average
age of sixty-one years at the time of surgery (range
38 to 74 years old). The etiology of the preopera-
tive condition was as follows: periprosthetic proxi -
mal femoral fracture (n=4); aseptic loosening of to-
tal hip prosthesis – femoral component – (n=3);
primary total hip prosthesis in congenital hip dis-
location in adult (n=1) and atrophic nonunion of
the femur (n=1). 
Twelve cortical strut allografts were used to re-
store femoral bone stock, reinforce the repair of
cortical windows, bypass stress risers, and as a bio -
logical plate to stabilize bone fractures and femoral
osteotomy. X rays were taken at 6 weeks and 3, 6,
and 12 months after surgery and yearly thereafter.
Cortical strut allografts of the tibia were pro-
cessed (debridement, cleaning and treatment in
70% ethanol and 30% hydrogen peroxide solu-
tions), aseptically preserved in liquid nitrogen, and
further prepared according to the HUC Tissue
Banking protocol (Figure 1) which is in agreement
with internationally accepted standards13,14.
The struts were fashioned to fit the femur. Ex-
cessive debridement of soft tissue was avoided to
preserve the periosteal circulation, and care was
taken to ensure adequate surface area between the
graft and the cortical layer of the femur without
interposition of soft tissue. The endosteal surface
of the allograft strut is contoured to match the ou -
ter diameter of the host femur, and the interfaces
are augmented with allograft cancellous bone
graft. To apply the strut allografts, the vastus late -
ralis was dissected of the linea aspera of the femur
and stripped it from the femur and retracted it an-
teriorly. 
The struts were fixed by metallic cables or by
the screws of the metallic plates, and most of them
were placed laterally to restore noncircumferential
bone loss (Figure 2). The average length of the
struts was 125 mm (range, 90 to 180 mm). In five
cases metallic plates were used in conjunction with
one or two cortical struts. Four patients were trea -
ted with cortical onlay strut allografts alone. In the
case of the atrophic nonunion, a metallic plate in
conjunction with cortical strut and cancellous
bone allograft were used. The cortical allograft was
fixed to the host femur with the screws of the
metallic plate.
Study of serial postoperative radiographs pro-
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duced a cortical strut categorization as follow: (1)
round off, (2) scalloping; (3) partial bridging, (4)
complete bridging, (5) cancellization, and (6) re-
sorption. A strut could have none, one, or any num-
ber of these conditions. This information was ana -
lyzed to determine the average time to union, the
percentage of struts that had united, and the allo-
graft resorption. Each strut was treated individu-
ally, despite some patients having more than one
strut. The radiographic criterion of union of strut
graft to host bone was defined as trabecular
bridgin g between any part of the graft and the host
femur9,15.
Results
The mean duration of follow-up was 4.3 years
(range, 1.6 to 9 years). Union was achieved along
the entire length of the cortical struts. All bone al-
lografts were incorporated as demonstrated by ra-
diography. A layer of new appositional bone was
observed in the interface graft-host bone, in an 
average postoperative follow-up period of 8
months (range, 6 to 12 months). No cases of nonu -
nion were noted. A consistent callus formation was
observed at 8 months of the postoperative period
in the clinical situation of nonunion of the femur.
There was no failure of any of the allograft recons -
tructions.
Progressive resorption of the allografts was not
observed. The minor localized resorption was
usual ly seen at the sites of cables but no other re-
sorption could be measured. There was a slight loss
of length of strut grafts by the remodeling process
at the ends of the allograft. No cases of strut frac-
tures were noted.
In the case of the congenital hip dislocation, a dis-
location of the total hip prosthesis and a superficial
infection (cellulite) were noted and successfully
treated with antibiotics without significant reper-
cussion on the clinical and radiographic results.
Discussion
The treatment of periprosthetic femoral fractures,
aseptic loosening of total hip prostheses, congeni -
tal hip dislocation in adults and nonunion of the
femur remains challenging. These clinical situa-
tions can be effectively treated with metallic im-
plants in conjunction with some forms of bone
grafting. Segmental loss of cortical bone from the
proximal femur is common in revision surgery.
Bone allografting is becoming a common proce-
dure in the orthopaedic operating room. Cortical
onlay strut allografts are used as biological bone
plate, with or without a metallic plate fixation, and
they are an extremely versatile resource for the re-
constructive surgery of osteoarticular prostheses
replacement and also in orthopaedic trauma
surgery. Appro priate placement of the graft is cri -
tical8,16-19.
In our study twelve cryopreserved cortical on-
lay strut allografts were radiographically analyzed,
demonstrating satisfactory mechanical results. In
fact, evidence of strut-to-host bridging was seen in
all of the patients, and no cases of progressive graft
resorption or graft fracture were noted (Figure 3).
There was no failure of any of the allograft recons -
tructions. They were consistently united to bone
and restored bone stock. These grafts performed
Figure 1. Preparation of a tibial cortical strut allografting.
Figure 2 a) and b). Surgical treatment of an aseptic
loosening of a total prosthesis using a cementless femoral
stem revision and a cortical onlay strut allografting 
(arrows), with 5 years of follow-up. Reconstruction of the
acetabulum with a metallic cage and particulate cancellous
bone allograft.
a b
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better when stabilized with metallic cables in close
proximity to vascularized host bone.
Cancellous bone allografts were placed between
the ends of the struts and the host bone, because
they promote the bone healing process and en-
hance strut-to-host bone union17,20,21. Strut union
was seen within the first year after surgery. Studies
of retrieved specimens have shown a close correla-
tion between radiographic evidence of union and
histologic observations22. Gradual callus formation
occurs at the junction site, extending from the pe-
riosteal surface of the native bone to the outer sur-
face of the cortical bone allograft. There is some
degree of creeping substitution at the allograft host
junction, but the bulk of the cortical strut remains
dead but structurally intact. On the external surface
of the allograft, mesenchymal proliferation from
the adjacent host cells leads to a thin layer of bone
formation that becomes incorporated into the al-
lograft cortex. In fact, the initial host response to the
allograft bone strut is rapid mobilization of me -
senchymal tissue, initiating intense osteogenesis.
The healing process of cortical allograft to host
bone is prolonged, following the steps of he ma -
toma formation, inflammatory process, resorption
of graft bone and revascularization, and finally re-
placement of graft with new host bone. Neverthe-
less, the graft is never entirely replaced with new
host bone4,5.
Processed and preserved bone allografts are
favoured in clinical practice. Processing involves
the removal of antigenic cells and proteins; preser-
vation techniques include deep-freezing or freeze-
drying. Deep frozen cortical struts retain their me-
chanical properties and may be implanted after
thawing, however, freeze-dried cortical struts are
vulnerable in torsion and bending, because freeze-
drying may alter the mechanical properties of the
bone23-25. We therefore used struts stored in liquid
nitrogen (cryopreserved) in order to achieve im-
mediate structural support.
In the case of treatment of the atrophic no -
nunion two very important requisites for success-
ful bone formation were achieved: vascularity and
mechanical stability. These factors are largely sur-
geon-dependent and emphasise the importance of
the surgical approach and the preparation of the
site to be grafted. 
Conclusion
Cryopreserved cortical onlay strut allografts act as
biological bone plates, serving both a mechanical
and a biological function. The results obtained in
the present study show that the use of cortical
struts, either alone or in conjunction with a metal-
lic plate or with cancellous bone allografts, is a use-
ful adjunct for revision hip arthroplasty of the
femoral side, stabilization of femoral periprosthe -
tic fractures, reinforcement of poor cortical bone
and for the treatment of femoral nonunion.
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